<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eye (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Eye (Lond)</journal-id><journal-id journal-id-type="pmc-domain-id">1476</journal-id><journal-id journal-id-type="pmc-domain">eye</journal-id><journal-title-group><journal-title>Eye</journal-title></journal-title-group><issn pub-type="ppub">0950-222X</issn><issn pub-type="epub">1476-5454</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11733160</article-id><article-id pub-id-type="pmcid-ver">PMC11733160.1</article-id><article-id pub-id-type="pmcaid">11733160</article-id><article-id pub-id-type="pmcaiid">11733160</article-id><article-id pub-id-type="pmid">39402169</article-id><article-id pub-id-type="doi">10.1038/s41433-024-03390-w</article-id><article-id pub-id-type="publisher-id">3390</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Risk factors for endogenous endophthalmitis in infectious endocarditis patients</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Shah</surname><given-names initials="MK">Megh K.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5323-7157</contrib-id><name name-style="western"><surname>Zhu</surname><given-names initials="A">Aretha</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Uppuluri</surname><given-names initials="A">Aditya</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Henry</surname><given-names initials="RK">Roger K.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zarbin</surname><given-names initials="MA">Marco A.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Bhagat</surname><given-names initials="N">Neelakshi</given-names></name><address><email>bhagatne@njms.rutgers.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/014ye1258</institution-id><institution-id institution-id-type="ISNI">0000 0000 8936 2606</institution-id><institution>Institute of Ophthalmology &amp; Visual Science, </institution><institution>Rutgers New Jersey Medical School, </institution></institution-wrap>Newark, NJ 07103 USA </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><volume>39</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">479607</issue-id><fpage>125</fpage><lpage>132</lpage><history><date date-type="received"><day>5</day><month>7</month><year>2023</year></date><date date-type="rev-recd"><day>26</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>4</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>16</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-28 18:25:16.407"><day>28</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41433_2024_Article_3390.pdf"/><abstract id="Abs1"><sec><title>Background/Objectives</title><p id="Par1">The purpose of this study was to identify demographic variables and systemic comorbidities that may increase risk of endogenous endophthalmitis (EE) development in patients with infective endocarditis (IE).</p></sec><sec><title>Subjects/Methods</title><p id="Par2">A retrospective database study was conducted using the 2002&#8211;2014 National Inpatient Sample (NIS). Patients with IE and EE were identified using ICD-9-CM codes. Descriptive chi-square and logistic regression analysis identified risk factors for EE in IE patients.</p></sec><sec><title>Results</title><p id="Par3">Of 769,472 inpatients with a diagnosis of IE, 2248 had a diagnosis of EE. Women comprised 39.7% of IE patients without EE and 42.6% of those with EE (<italic toggle="yes">p</italic>&#8201;=&#8201;0.005). The majority of IE cases with EE were in those 21&#8211;64-year-old (58.5%) age cohort and 67.4% of cases were Whites. Multivariate analysis revealed IE patients in the 21&#8211;64 (OR, 3.660) and 65+ age group (OR, 2.852) had increased risk of developing EE compared to the 0&#8211;20-year-old group. Hispanic (OR, 1.377) and Asian/Pacific Islander (OR, 1.620) patients had increased risk compared to White patients. Diabetes with (OR, 2.043) and without (OR, 1.433) chronic complications, alcohol use disorder (AUD; OR, 1.795), and cirrhosis (OR, 1.452) conferred an increased risk of developing EE, whereas, congestive heart failure (CHF; OR, 0.716), arrhythmia (OR, 0.678), and having a cardiac device (OR, 0.336) decreased risk of EE in IE subjects.</p></sec><sec><title>Conclusion</title><p id="Par4">Older age (21+ years) and Hispanic and Asian/Pacific Islander background were associated with increased risk of developing EE in IE patients. Diabetes with and without chronic complications, AUD, or cirrhosis also conferred a 1.5&#8211;2 times increased risk. CHF, arrhythmia, or having a cardiac device were associated with decreased risk.</p></sec></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Risk factors</kwd><kwd>Epidemiology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Royal College of Ophthalmologists 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par5">Endogenous endophthalmitis (EE), a potentially severe purulent infection, results from hematogenous spread of bacteria or fungus from a remote source. It is associated with poor visual outcomes and, in some cases, increased risk of mortality. Approximately, 90% of EE patients have underlying systemic comorbidities such as diabetes and cardiac disease [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Infective endocarditis (IE) is one of the most common sources of EE [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>]. Cases of endophthalmitis resulting from endocarditis with various infective organisms, including culture-negative bacteria (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, and Kingella, collectively termed HACEK) and <italic toggle="yes">Candida</italic>, have been documented [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>]. Previous studies have reported systemic risk factors for EE [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In this study, we sought to evaluate the risk factors for EE in patients specifically with IE. Additionally, we also investigated the impact of potential cardiac risk factors, such as history of arrhythmia and valvular disease on developing EE in the setting of IE [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par6">A retrospective cross-sectional case-control study was done to identify comorbidities associated with a diagnosis of EE in patients with IE. Identification of risk factors for development of EE in IE patients, can lead to improved vigilance for early diagnosis of a potentially blinding condition.</p></sec><sec id="Sec2"><title>Materials/Subjects and methods</title><p id="Par7">The 2002&#8211;2014 National Inpatient Sample (NIS) Database was used to perform this retrospective cross-sectional study. The NIS database, developed for the Healthcare Cost and Utilization Project (HCUP), is a publicly available all-payer inpatient healthcare database containing information from about 7 million unweighted hospital admissions nationally each year [<xref ref-type="bibr" rid="CR12">12</xref>]. The database reports demographic information, including age, sex, and race. Age groups used in this study included &lt;20, 20&#8211;64, and &gt;65 year old cohorts, which encompass the paediatric, adult, and older population groups. Previous literature has documented varying rates of IE incidence, risk factor incidence, and mortality between these age groups [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. The NIS database also includes hospitalization metrics (cost and length of stay, insurance coverage, discharge quarter), current and previous diagnoses, and inpatient procedures. This data is coded in NIS by participating physicians using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Weighted data from the NIS database are used to estimate inpatient utilization and outcomes on both a regional and national level [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par8">The ICD-9-CM was used in conjunction with the NIS database to identify diagnoses of IE, EE, and systemic comorbidities. First, inpatients with IE were included if they had a diagnosis of bacterial/Candida infectious endocarditis, or a diagnosis of non-specific/non-infectious endocarditis with concurrent septicaemia/Candidemia. Inpatients with concurrent EE were subsequently identified. Cases with concurrent diagnosis of open globe injury were removed to exclude any eyes with traumatic endophthalmitis. A &#8220;control&#8221; cohort with IE without EE and &#8220;case&#8221; cohort with both IE and EE were identified. Post-surgical endophthalmitis cases could not be excluded since the ICD-9-CM code for these cases are not reported in the NIS; however, the incidence of post-surgical endophthalmitis reported in literature is very low: 0.02&#8211;0.71% [<xref ref-type="bibr" rid="CR16">16</xref>]. The methodology used in our study to identify EE cases is reported in prior literature [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par9">ICD-9 diagnosis codes for systemic variables used in this study are reported in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. The study used a validated Johns Hopkins Adjusted Clinical Groups frailty-defining diagnoses indicator algorithm to identify patients with frailty [<xref ref-type="bibr" rid="CR20">20</xref>]. An algorithm by Tookes et al. [<xref ref-type="bibr" rid="CR21">21</xref>] was used to identify cases with documented drug use disorder and an IV drug use-associated complication. Column counts in Tables&#160;<xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref> are based on the total identified cases of EE in the entire isolated cohort of patients with IE. Individual variables may be inconsistently reported for each patient and as such variable totals may not be equivalent to column counts.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>List of variables with corresponding international classification of diseases, ninth revision, codes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">International classification of diseases, ninth revision, codes</th></tr></thead><tbody><tr><td colspan="2" rowspan="1">Systemic variables</td></tr><tr><td colspan="1" rowspan="1">&#8195;Immunosuppression</td><td colspan="1" rowspan="1">Composite of V42.0, V42.1, V42.6, V42.7, V42.83, V42.84, 37.51, 33.5&#8211;33.52, 33.6, 50.5, 50.51, 50.59, 52.8, 52.80, 52.82, 52.83, 46.97, V87.41, V58.1, V58.11, V58.12, 042, 279.0279.06, 279.09, 279.1&#8211;279.13, 279.19, 279.2, 279.3, 279.4, 279.8, 279.9, V58.65, AIDS variable supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;Arrhythmia</td><td colspan="1" rowspan="1">427.0, 427.42, 427.31, 427.32, 427.1, 427.9, 427.41</td></tr><tr><td colspan="1" rowspan="1">&#8195;Cardiac device</td><td colspan="1" rowspan="1">V45.01, V45.02</td></tr><tr><td colspan="1" rowspan="1">&#8195;Valvular disease</td><td colspan="1" rowspan="1">Supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;Organ infection</td><td colspan="1" rowspan="1">528.3, 522.4, 521.00, 522.0, 523.10, 522.7, 522.6, 522.5, 461, 462, 463, 464, 465, 481, 482, 491.21, 494, 510, 513, 711.0, 730, 681&#8211;683, 686, 590, 597, 599.0, 601, 614, 615, 616, 540&#8211;541, 562.01, 562.03, 562.11, 562.13, 556, 567, 5695, 572, 572.1, 575.0, 320, 322, 324, 325, 996.6, 451</td></tr><tr><td colspan="1" rowspan="1">&#8195;Chronic kidney disease</td><td colspan="1" rowspan="1">585.1&#8211;585.6, 585.9, 586</td></tr><tr><td colspan="1" rowspan="1">&#8195;Cirrhosis</td><td colspan="1" rowspan="1">571.2, 571.5, 571.6</td></tr><tr><td colspan="1" rowspan="1">&#8195;Alcohol use disorder</td><td colspan="1" rowspan="1">303, 303.0, 303.01, 303.02, 303.03, 303.9, 303.91, 303.92, 303.93, 305.0, 305.01, 305.02, 305.03</td></tr><tr><td colspan="1" rowspan="1">&#8195;Congestive heart failure</td><td colspan="1" rowspan="1">Supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetes without chronic complications</td><td colspan="1" rowspan="1">Supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetes with chronic complications</td><td colspan="1" rowspan="1">Composite of variable supplied by National Inpatient Sample database and diabetic retinopathy (362.0, 362.01, 362.02, 362.03, 362.04, 362.05, 362.06)</td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetic ketoacidosis</td><td colspan="1" rowspan="1">250.1&#8211;250.13</td></tr><tr><td colspan="1" rowspan="1">&#8195;Hypertension</td><td colspan="1" rowspan="1">Supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;Obesity</td><td colspan="1" rowspan="1">Supplied by National Inpatient Sample database</td></tr><tr><td colspan="1" rowspan="1">&#8195;IV drug use</td><td colspan="1" rowspan="1">Uses algorithm detailed in &#8220;Methods&#8221;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Radiation therapy</td><td colspan="1" rowspan="1">V58.0, V15.3</td></tr><tr><td colspan="1" rowspan="1">&#8195;Tobacco use</td><td colspan="1" rowspan="1">305.1, V15.82</td></tr><tr><td colspan="1" rowspan="1">&#8195;Frailty</td><td colspan="1" rowspan="1">261, 262, 263.8, 263.9, V77.2, 290.20, 290.21, 290.3, 369.0, 369.00, 369.01, 369.03, 369.04, 369.06, 369.07, 369.08, 707.0, 707.00&#8211;707.07, 707.09, 707.20&#8211;707.25, 788.34, 788.37, 787.6, V60.0-V60.2, 719.7, 781.2, E880, E880.0, E880.1, E880.9, E884.3</td></tr></tbody></table></table-wrap><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Descriptive table of demographic variables, hospital stay information.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">No endophthalmitis (<italic toggle="yes">n</italic>&#8201;=&#8201;767224)</th><th colspan="1" rowspan="1">Endophthalmitis (<italic toggle="yes">n</italic>&#8201;=&#8201;2248)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Gender, no. (%)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><bold>0.005</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Male</td><td colspan="1" rowspan="1">462,856 (60.3%)</td><td colspan="1" rowspan="1">1292 (57.4%)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#8195;Female</td><td colspan="1" rowspan="1">304,228 (39.7%)</td><td colspan="1" rowspan="1">957 (42.6%)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="4" rowspan="1">Age group (yrs), no. (%)</td></tr><tr><td colspan="1" rowspan="1">&#8195;0&#8211;20</td><td colspan="1" rowspan="1">15,857 (2.1%)</td><td colspan="1" rowspan="1">15 (0.7%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;21&#8211;64</td><td colspan="1" rowspan="1">379,541 (49.5%)</td><td colspan="1" rowspan="1">1314 (58.5%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;65+</td><td colspan="1" rowspan="1">371,780 (48.5%)</td><td colspan="1" rowspan="1">919 (40.9%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="4" rowspan="1">Race, no. (%)</td></tr><tr><td colspan="1" rowspan="1">&#8195;White</td><td colspan="1" rowspan="1">459,297 (70.8%)</td><td colspan="1" rowspan="1">1326 (67.4%)</td><td colspan="1" rowspan="1"><bold>0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Black</td><td colspan="1" rowspan="1">102,274 (15.8%)</td><td colspan="1" rowspan="1">260 (13.2%)</td><td colspan="1" rowspan="1"><bold>0.002</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Hispanic</td><td colspan="1" rowspan="1">52,848 (8.2%)</td><td colspan="1" rowspan="1">263 (13.4%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Asian or Pacific Islander</td><td colspan="1" rowspan="1">12,178 (1.9%)</td><td colspan="1" rowspan="1">61 (3.1%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Native American</td><td colspan="1" rowspan="1">4015 (0.6%)</td><td colspan="1" rowspan="1"><sup>a</sup></td><td colspan="1" rowspan="1"><bold>0.039</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Other</td><td colspan="1" rowspan="1">17,826 (2.7%)</td><td colspan="1" rowspan="1">53 (2.7%)</td><td colspan="1" rowspan="1">0.879</td></tr><tr><td colspan="4" rowspan="1">Discharge quarter, no. (%)</td></tr><tr><td colspan="1" rowspan="1">&#8195;1 (January&#8211;March)</td><td colspan="1" rowspan="1">184,745 (24.1%)</td><td colspan="1" rowspan="1">580 (25.8%)</td><td colspan="1" rowspan="1">0.064</td></tr><tr><td colspan="1" rowspan="1">&#8195;2 (April&#8211;June)</td><td colspan="1" rowspan="1">192,449 (25.1%)</td><td colspan="1" rowspan="1">495 (22.0%)</td><td colspan="1" rowspan="1"><bold>0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;3 (July&#8211;September)</td><td colspan="1" rowspan="1">195,863 (25.6%)</td><td colspan="1" rowspan="1">491 (21.8%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;4 (October&#8211;December)</td><td colspan="1" rowspan="1">192,929 (25.2%)</td><td colspan="1" rowspan="1">683 (30.4%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="4" rowspan="1">Hospital course</td></tr><tr><td colspan="1" rowspan="1">&#8195;Average length of stay (days)</td><td colspan="1" rowspan="1">13.83</td><td colspan="1" rowspan="1">18.03</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Average cost of hospital stay (dollars)</td><td colspan="1" rowspan="1">109,191.52</td><td colspan="1" rowspan="1">146,501.96</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Death during hospitalization, no. (%)</td><td colspan="1" rowspan="1">83,590 (10.9%)</td><td colspan="1" rowspan="1">296 (13.2%)</td><td colspan="1" rowspan="1"><bold>0.001</bold></td></tr><tr><td colspan="4" rowspan="1">Insurance, no. (%)</td></tr><tr><td colspan="1" rowspan="1">&#8195;Government</td><td colspan="1" rowspan="1">542,979 (70.8%)</td><td colspan="1" rowspan="1">1471 (65.4%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Private</td><td colspan="1" rowspan="1">162,659 (21.2%)</td><td colspan="1" rowspan="1">464 (20.6%)</td><td colspan="1" rowspan="1">0.509</td></tr><tr><td colspan="1" rowspan="1">&#8195;Other</td><td colspan="1" rowspan="1">60,127 (7.8%)</td><td colspan="1" rowspan="1">304 (13.5%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr></tbody></table><table-wrap-foot><p>Bold values represent significant <italic toggle="yes">p</italic> values.</p><p><sup>a</sup>Cells with 1&#8211;10 patients are represented with an asterisk in compliance with the Healthcare Cost and Utilization Project guidelines on reporting National Inpatient Sample data.</p></table-wrap-foot></table-wrap><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Descriptive table of systemic comorbidities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Systemic comorbidities</th><th colspan="1" rowspan="1">No endophthalmitis (<italic toggle="yes">n</italic>&#8201;=&#8201;767,224)</th><th colspan="1" rowspan="1">Endophthalmitis (<italic toggle="yes">n</italic>&#8201;=&#8201;2248)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Congestive heart failure</td><td colspan="1" rowspan="1">143,652 (18.9%)</td><td colspan="1" rowspan="1">340 (15.2%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Diabetes without chronic complications</td><td colspan="1" rowspan="1">151,867 (19.9%)</td><td colspan="1" rowspan="1">533 (23.8%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Diabetes with chronic complications</td><td colspan="1" rowspan="1">59,250 (7.7%)</td><td colspan="1" rowspan="1">308 (13.7%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Hypertension</td><td colspan="1" rowspan="1">378,171 (49.7%)</td><td colspan="1" rowspan="1">1083 (48.4%)</td><td colspan="1" rowspan="1">0.228</td></tr><tr><td colspan="1" rowspan="1">Obesity</td><td colspan="1" rowspan="1">57,296 (7.5%)</td><td colspan="1" rowspan="1">224 (10.0%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Valvular disease</td><td colspan="1" rowspan="1">152,994 (20.1%)</td><td colspan="1" rowspan="1">572 (25.5%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Immunosuppression</td><td colspan="1" rowspan="1">21,079 (2.7%)</td><td colspan="1" rowspan="1">46 (2.0%)</td><td colspan="1" rowspan="1"><bold>0.042</bold></td></tr><tr><td colspan="1" rowspan="1">Arrhythmia</td><td colspan="1" rowspan="1">216,562 (28.2%)</td><td colspan="1" rowspan="1">456 (20.3%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Cardiac device</td><td colspan="1" rowspan="1">44,216 (5.8%)</td><td colspan="1" rowspan="1">36 (1.6%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Organ infection</td><td colspan="1" rowspan="1">128,521 (16.8%)</td><td colspan="1" rowspan="1">377 (16.8%)</td><td colspan="1" rowspan="1">0.998</td></tr><tr><td colspan="1" rowspan="1">Chronic kidney disease</td><td colspan="1" rowspan="1">157,938 (20.6%)</td><td colspan="1" rowspan="1">467 (20.8%)</td><td colspan="1" rowspan="1">0.825</td></tr><tr><td colspan="1" rowspan="1">Cirrhosis</td><td colspan="1" rowspan="1">19,680 (2.6%)</td><td colspan="1" rowspan="1">115 (5.1%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Alcohol use disorder</td><td colspan="1" rowspan="1">9448 (1.2%)</td><td colspan="1" rowspan="1">64 (2.8%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Diabetic ketoacidosis</td><td colspan="1" rowspan="1">4085 (0.5%)</td><td colspan="1" rowspan="1">39 (1.7%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">Radiation therapy</td><td colspan="1" rowspan="1">1556 (0.2%)</td><td colspan="1" rowspan="1"><sup>a</sup></td><td colspan="1" rowspan="1">0.811<sup>b</sup></td></tr><tr><td colspan="1" rowspan="1">Tobacco use</td><td colspan="1" rowspan="1">97,600 (12.7%)</td><td colspan="1" rowspan="1">230 (10.2%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">IV drug use</td><td colspan="1" rowspan="1">60,597 (7.9%)</td><td colspan="1" rowspan="1">212 (9.4%)</td><td colspan="1" rowspan="1"><bold>0.007</bold></td></tr><tr><td colspan="1" rowspan="1">Frailty</td><td colspan="1" rowspan="1">114,594 (14.9%)</td><td colspan="1" rowspan="1">440 (19.6%)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr></tbody></table><table-wrap-foot><p>Bold values represent significant <italic toggle="yes">p</italic> values.</p><p><sup>a</sup>Cells with 1&#8211;10 patients are represented with an asterisk in compliance with the Healthcare Cost and Utilization Project guidelines on reporting National Inpatient Sample data.</p><p><sup>b</sup><italic toggle="yes">P</italic> values denoted by two asterisks indicate Fisher&#8217;s exact tests were used.</p></table-wrap-foot></table-wrap></p><p id="Par10">Statistical analysis was performed with IBM SPSS software v25 (IBM, Armonk, NY). Chi square testing compared demographics, systemic comorbidities, morbidity during hospitalization, and discharge quarter between case and control cohorts. Independent samples t-testing was used to compare cost per day and length of stay. Binary logistic regression analysis was performed with IBM SPSS v25 to identify risk factors for EE in cases with IE. Univariate regression used the level of significance <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05. Bonferroni correction was applied to the multivariate logistic regression tests to minimize the type I error.</p><p id="Par11">This study, which adhered to the tenets of the Declaration of Helsinki, received exemption by the Rutgers University Institutional Review Board due to non-human determination according to the National Bureau of Economic Research [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec3" sec-type="results"><title>Results</title><p id="Par12">Of 769,472 total IE patients included in the study, 2,248 (0.29%) had EE. Mean ages of cases (IE patients with EE) and controls (IE patients without EE) were 59.5 years and 61.4 years (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), respectively. Table&#160;<xref rid="Tab2" ref-type="table">2</xref> shows results of chi square analysis and independent samples t-testing comparing the percentage of IE patients with and without EE across demographic variables (gender, age group, race) and hospital stay information (discharge quarter, hospital course, insurance). Women comprised 42.6% of cases but only 39.7% of controls (<italic toggle="yes">p</italic>&#8201;=&#8201;0.005). Most IE patients with and without EE were White. Descriptive statistical analysis (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>) noted a significantly higher proportion of cases (with endophthalmitis) than controls in the 21&#8211;64 aged cohort, 58.5% vs 49.5% (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), respectively. The average length of stay was significantly longer in IE patients with EE (18.03 days vs. 13.8 days; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). The average cost per day of hospitalization was also significantly higher in IE patients with EE ($146,501.96) than those without ($109,191.52; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). The mortality rate for EE group was 13.2% compared to 10.9% in the non-EE group (<italic toggle="yes">p</italic>&#8201;=&#8201;0.001).</p><p id="Par13">Table&#160;<xref rid="Tab3" ref-type="table">3</xref> presents the results of chi-square analysis comparing the prevalence of systemic comorbidities. Diabetes with and without chronic complications, obesity, valvular disease, liver cirrhosis, alcohol use disorder, diabetic ketoacidosis, IV drug use, and frailty were significantly more prevalent in IE patients with EE (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Meanwhile, congestive heart failure, immunosuppression, arrhythmia, history of cardiac device, and tobacco use were less prevalent in IE patients with EE (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p><p id="Par14">Univariate and multivariate logistic regression analysis of demographic variables and systemic conditions associated with a significantly increased or decreased risk of EE are presented in Table&#160;<xref rid="Tab4" ref-type="table">4</xref>. There was no significant gender difference in risk of developing EE. With respect to age, IE patients in the 21&#8211;64 (odds ratio [OR], 3.660; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) and 65+ (OR, 2.852; <italic toggle="yes">p</italic>&#8201;=&#8201;0.001) year old cohorts showed a significantly increased risk of developing EE compared to patients in the 0&#8211;20-year-old age group. With respect to race, Hispanic (OR, 1.377; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) and Asian/Pacific Islander (OR 1.620; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) patients had a greater risk of EE compared to White patients. Among systemic comorbidities, diabetes without chronic complications (OR, 1.433; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), diabetes with chronic complications (OR, 2.043; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), cardiac valvular disease (OR, 1.422; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), cirrhosis (OR, 1.452; <italic toggle="yes">p</italic>&#8201;=&#8201;0.001), and alcohol use disorder (OR, 1.795; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) were associated with an increased risk of developing EE. Meanwhile, congestive heart failure (OR, 0.716; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), arrhythmia (OR, 0.678; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), and history of cardiac device (OR, 0.336; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) were associated with a decreased risk. Our results did not show a statistically significant difference in developing EE with obesity, immunosuppression, diabetic ketoacidosis, tobacco use, IV drug use (IVDU), and frailty using multivariate analysis.<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Results of logistic regression.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Univariate</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th><th colspan="1" rowspan="1">Multivariate</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">Gender</td></tr><tr><td colspan="1" rowspan="1">&#8195;Male</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Female</td><td colspan="1" rowspan="1">1.127 (1.036&#8211;1.225)</td><td colspan="1" rowspan="1">0.005</td><td colspan="1" rowspan="1">1.090 (0.987&#8211;1.204)</td><td colspan="1" rowspan="1">0.089</td></tr><tr><td colspan="5" rowspan="1">Age group (yrs)</td></tr><tr><td colspan="1" rowspan="1">&#8195;0&#8211;20</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;21&#8211;64</td><td colspan="1" rowspan="1">3.616 (2.180&#8211;5.998)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">3.660 (1.965&#8211;6.818)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;65+</td><td colspan="1" rowspan="1">2.580 (1.554&#8211;4.285)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">2.852 (1.527&#8211;5.324)</td><td colspan="1" rowspan="1"><bold>0.001</bold></td></tr><tr><td colspan="5" rowspan="1">Race</td></tr><tr><td colspan="1" rowspan="1">&#8195;White</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Reference</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Black</td><td colspan="1" rowspan="1">0.881 (0.771&#8211;1.006)</td><td colspan="1" rowspan="1">0.062</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Hispanic</td><td colspan="1" rowspan="1">1.725 (1.510&#8211;1.969)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.377 (1.200&#8211;1.580)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Asian or Pacific Islander</td><td colspan="1" rowspan="1">1.744 (1.349&#8211;2.254)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.620 (1.252&#8211;2.096)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Native American</td><td colspan="1" rowspan="1">0.398 (0.159&#8211;0.993)</td><td colspan="1" rowspan="1">0.048</td><td colspan="1" rowspan="1">0.328 (0.131&#8211;0.819)</td><td colspan="1" rowspan="1">0.017</td></tr><tr><td colspan="1" rowspan="1">&#8195;Other</td><td colspan="1" rowspan="1">1.028 (0.781&#8211;1.354)</td><td colspan="1" rowspan="1">0.842</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="5" rowspan="1">Systemic comorbidities</td></tr><tr><td colspan="1" rowspan="1">&#8195;Congestive heart failure</td><td colspan="1" rowspan="1">0.771 (0.687&#8211;0.865)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">0.716 (0.622&#8211;0.824)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetes without chronic complications</td><td colspan="1" rowspan="1">1.253 (1.137&#8211;1.381)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.433 (1.270&#8211;1.616)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetes with chronic complications</td><td colspan="1" rowspan="1">1.898 (1.683&#8211;2.141)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">2.043 (1.763&#8211;2.368)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Hypertension</td><td colspan="1" rowspan="1">0.950(0.874&#8211;1.032)</td><td colspan="1" rowspan="1">0.224</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Obesity</td><td colspan="1" rowspan="1">1.369 (1.192&#8211;1.571)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.014 (0.855&#8211;1.203)</td><td colspan="1" rowspan="1">0.869</td></tr><tr><td colspan="1" rowspan="1">&#8195;Valvular disease</td><td colspan="1" rowspan="1">1.364 (1.240&#8211;1.500)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.422 (1.268&#8211;1.593)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Immunosuppression</td><td colspan="1" rowspan="1">0.741 (0.553&#8211;0.992)</td><td colspan="1" rowspan="1">0.044</td><td colspan="1" rowspan="1">0.865 (0.621&#8211;1.204)</td><td colspan="1" rowspan="1">0.390</td></tr><tr><td colspan="1" rowspan="1">&#8195;Arrhythmia</td><td colspan="1" rowspan="1">0.647 (0.584&#8211;0.718)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">0.678 (0.599&#8211;0.769)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Cardiac device</td><td colspan="1" rowspan="1">0.267 (0.192&#8211;0.371)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">0.336 (0.235&#8211;0.479)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Organ infection</td><td colspan="1" rowspan="1">1.000 (0.895&#8211;1.117)</td><td colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Chronic kidney disease</td><td colspan="1" rowspan="1">1.011 (0.913&#8211;1.120)</td><td colspan="1" rowspan="1">0.829</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Cirrhosis</td><td colspan="1" rowspan="1">2.053 (1.701&#8211;2.478)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.452 (1.156&#8211;1.825)</td><td colspan="1" rowspan="1"><bold>0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Alcohol use disorder</td><td colspan="1" rowspan="1">2.357 (1.837&#8211;3.023)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.795 (1.313&#8211;2.455)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td></tr><tr><td colspan="1" rowspan="1">&#8195;Diabetic ketoacidosis</td><td colspan="1" rowspan="1">3.269 (2.375&#8211;4.499)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.687 (1.116&#8211;2.549)</td><td colspan="1" rowspan="1">0.013</td></tr><tr><td colspan="1" rowspan="1">&#8195;Radiation therapy</td><td colspan="1" rowspan="1">1.097 (0.456&#8211;2.642)</td><td colspan="1" rowspan="1">0.836</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">&#8195;Tobacco use</td><td colspan="1" rowspan="1">0.783 (0.683&#8211;0.898)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">0.811 (0.693&#8211;0.948)</td><td colspan="1" rowspan="1">0.008</td></tr><tr><td colspan="1" rowspan="1">&#8195;IV drug use</td><td colspan="1" rowspan="1">1.212 (1.052&#8211;1.397)</td><td colspan="1" rowspan="1">0.008</td><td colspan="1" rowspan="1">1.068 (0.892&#8211;1.279)</td><td colspan="1" rowspan="1">0.473</td></tr><tr><td colspan="1" rowspan="1">&#8195;Frailty</td><td colspan="1" rowspan="1">1.385 (1.248&#8211;1.538)</td><td colspan="1" rowspan="1"><bold>&lt;0.001</bold></td><td colspan="1" rowspan="1">1.113 (0.977&#8211;1.267)</td><td colspan="1" rowspan="1">0.106</td></tr></tbody></table><table-wrap-foot><p>Bold values represent significant <italic toggle="yes">p</italic> values.</p><p>Bonferroni correction: new alpha cutoff&#8201;=&#8201;<bold>0.0029</bold> (0.05/17). Bold value represents the new alpha cutoff after Bonferroni correction, which was applied to this Table.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4" sec-type="discussion"><title>Discussion</title><p id="Par15">In our population of IE patients, 0.29% had EE. While there is a dearth of literature on the prevalence of EE in patients with IE, risk factors for development of EE as reported in the literature include: IVDU, bacteraemia, endocarditis, urinary tract infections, dental abscess, liver abscess, COVID-19 infection, indwelling central venous catheters, presence of a pacemaker, contaminated IV infusion, and procedures such as endoscopy [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>]. While previous literature has reported IE as a risk factor for EE [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], this study aims to explore risk factors for EE in patients admitted to hospitals with IE.</p><p id="Par16">Systemic comorbidities that increased the risk of developing EE in IE patients were diabetes with (2-fold) and without (1.4-fold) chronic complications, cardiac valvular disease (1.4-fold), cirrhosis (1.5-fold), and alcohol use disorder (1.8-fold). Individuals with diabetes exhibit poor phagocytic function and cellular immunity which can contribute to an increased risk of infections and infectious complications [<xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref>]. Diabetes-induced endothelial dysfunction may promote the risk of bacterial colonization and infection [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Another condition associated with an increased risk of the development of EE in IE patients was cardiac valvular disease. Cardiac valvular disease can increase risk of vegetations, as injured endothelium can cause microthrombosis [<xref ref-type="bibr" rid="CR39">39</xref>]. These vegetations are shielded from access by the host immune system and as such can become colonized by bloodborne bacteria that can cause microvascular embolization like EE [<xref ref-type="bibr" rid="CR39">39</xref>]. Pre-existing cardiac valvular disease undergoing surgical procedures such as valve replacement may further increase the risk of septicaemia and EE [<xref ref-type="bibr" rid="CR40">40</xref>]. Further, postsurgical or postprocedural infections may also contribute to the development of EE in patients with cardiac valvular disease [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par17">While IVDU is a well-established risk factor for the development of endocarditis, our study did not find that it increased the risk of EE in IE patients [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In the current study, alcohol use disorder showed a significantly increased risk of EE development in IE patients. Alcohol use disorder can result in immunomodulation through derangements of the hypothalamic-pituitary-adrenal axis, the cytokine profile, and immune cell function [<xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>]. Cirrhosis has been shown by the current study and prior studies to be a risk factor for the EE [<xref ref-type="bibr" rid="CR46">46</xref>&#8211;<xref ref-type="bibr" rid="CR48">48</xref>]. Cirrhosis can disrupt the mounting of normal immune responses and can cause cirrhosis-associated immunodeficiency, a factor that may promote a more severe infection [<xref ref-type="bibr" rid="CR49">49</xref>]. Decreased circulating albumin in cirrhosis causes a lack of sequestration of PGE<sub>2</sub>, a molecule that normally promotes immunosuppression [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par18">Older age was another risk factor for the diagnosis EE in our cohort of IE. Multivariate analysis showed that the two older age cohorts, 21&#8211;64 and 65+ years, were significantly more likely to develop EE compared to the 0&#8211;20 year group. Aging is associated with the development of physiological immunosenescence, a process that has been linked to an increase in the risk for bacterial infections, diabetes, and malignancies in older individuals, which may explain the higher odds of developing EE with age [<xref ref-type="bibr" rid="CR50">50</xref>]. Frailty was found to be a significant risk factor for EE on univariate analysis, but not on multivariate analysis. In a 2022 retrospective study of septicaemic patients using the NIS database from the same time period as the current study, Henry et al. found frailty to be a significant risk factor for EE in older patients with septicemia [<xref ref-type="bibr" rid="CR20">20</xref>]. Many of the frailty defining diagnoses have been associated with factors that may predispose patients to EE [<xref ref-type="bibr" rid="CR20">20</xref>]. For example, cognitive decline and poor nutrition status have been associated with retinal microvascular abnormalities in the elderly [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par19">Interestingly, the current study found a decrease in the risk of EE in IE patients with arrhythmias, cardiac devices, or congestive heart failure. The risk of endophthalmitis in IE patients with heart failure and cardiac devices has not been well described in the literature, but many case reports of infected cardiac devices resulting in endophthalmitis are published [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR51">51</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>]. As per our communication with cardiologists, this seemingly inverse relationship could be explained by the fact that these cardiac patients may routinely undergo annual or biannual echocardiography as part of their care, which may identify endocarditis earlier in the clinical course, starting antibiotics earlier in the course decreasing the risk of sepsis and septic emboli [<xref ref-type="bibr" rid="CR54">54</xref>]. It is uncertain why certain cardiac risk factors in our study, e.g., valvular disease, were associated with an increased risk of EE, while others, e.g., arrhythmia, were not. In a study by Uppuluri et al. on patients with atrial fibrillation and atrial flutter, endocarditis was associated with significantly increased risk of central retinal artery occlusion (CRAO) on univariate analysis [<xref ref-type="bibr" rid="CR55">55</xref>]. The mechanism of CRAO in these patients is emboli to the retinal arterial system from vegetations in IE. These septic emboli have the potential to seed the affected eye with pathogens and cause endophthalmitis as well, although the current study showed a decreased risk of developing EE in those IE subjects with arrhythmias. Further study is needed to elucidate the relationship between arrhythmias and EE in IE patients. Although our study did not investigate prevalence of comorbid CRAO, consideration should be given to risk of developing CRAO and EE in IE patients, as risk factors for EE such as valvular disease and diabetes are risk factors for CRAO as well [<xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par20">It is also interesting to note that while systemic factors that can cause secondary immunosuppression (e.g., diabetes, cirrhosis, and older age) were risk factors for EE in our study, primary immunosuppression was not. This may be due to diligent vigilance to diagnose infection as early as possible in primary immunosuppression (patients with organ transplantation, or patients undergoing cancer treatment etc). The goal is to start recognize and treat infection before septicaemia occurs to prevent septic emboli from reaching various organs like eyes; whereas in chronic diseases with secondary immunosuppression, smouldering infections can be recognized late increasing the risk of septic emboli to cause IE. In addition, when considering comorbidities such as diabetes and cirrhosis, other mechanisms in addition to immunosuppression may increase risk of EE, such as endothelial dysfunction in diabetic patients, and translocation of enteric bacteria in cirrhosis patients [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>].</p><p id="Par21">Hispanic and Asian or Pacific Islander patients with IE had a significantly increased risk of developing EE when compared to White patients in this study. A 2021 retrospective study by Seidelman et al. [<xref ref-type="bibr" rid="CR60">60</xref>] on 771 patients with <italic toggle="yes">Candidemia</italic> showed that Non-Caucasian/White individuals had significantly greater odds (1.65-fold) of developing Candida endophthalmitis compared to Caucasian/White individuals. Further studies are needed to elucidate how such racial differences are attributable to genetic or socioeconomic factors. Socioeconomic factors, including insurance status and education level, can also influence management of risk factors that may contribute to an increased risk of EE as well as management and treatment of EE [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par22">Patients with EE secondary to IE had significantly greater average cost during the hospital stay, increased length of hospital stay, and increased death rate during hospitalization. These findings are likely due to a more severe and disseminated disease course in patients with EE requiring more intense management. As EE can often be the first manifestation of IE, a high index of suspicion may allow for prompt diagnosis and identification of the source of infection [<xref ref-type="bibr" rid="CR29">29</xref>]. Further research is needed on the utility of screening for IE in patients with EE, as one negative TEE examination cannot be used to rule out endocarditis since patients may become positive later on in the disease course [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. The current results may support increased consideration of IE in patients with EE. Additionally, the prompt identification and treatment of EE secondary to IE may impact a patient&#8217;s clinical course. EE may be categorized by the infectious agent that is causing the endophthalmitis. Most cases of endogenous bacterial endocarditis (EBE) present acutely with 90% of patients reporting decreased vision and 50% having eye pain [<xref ref-type="bibr" rid="CR33">33</xref>]. EBE generally has poor visual outcomes [<xref ref-type="bibr" rid="CR33">33</xref>]. While data are minimal regarding the utility of screening for EE in patients with IE, one study on 111 patients meeting Duke criteria for endocarditis found that those patients who reported no visual symptoms had no retinal changes in need of intervention on dilated fundus examination, while those with symptoms had complications such as subretinal abscess [<xref ref-type="bibr" rid="CR62">62</xref>]. As such, patients with a diagnosis of bacterial endocarditis, especially those with vision symptoms or risk factors such as diabetes, alcohol use, or cirrhosis may require a higher index of suspicion for EE although no screening guidelines currently exist. Further study is warranted on this topic. Conversely, endogenous fungal endophthalmitis (EFE) generally presents with an indolent course, with <italic toggle="yes">Candidemia</italic> being the most common cause [<xref ref-type="bibr" rid="CR33">33</xref>]. EFE generally begins as chorioretinitis and progresses over time to vitritis and endophthalmitis [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. While the slowly progressive nature of endogenous fungal endophthalmitis seems to lend itself to early diagnosis and intervention, routine ophthalmologic screening after identification of <italic toggle="yes">Candida</italic> septicaemia has not been supported by the American Academy of Ophthalmology [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p><sec id="Sec5"><title>Limitations</title><p id="Par23">The National Inpatient Sample is the largest publicly available all-payer inpatient healthcare database [<xref ref-type="bibr" rid="CR12">12</xref>]. As such, the first limitation of this study is that the cases were only inpatients, as outpatients with IE were not included. Additionally, the diagnosis of endophthalmitis was made during the patient&#8217;s inpatient stay. As with any discharge database, causality cannot be determined as NIS does not provide a temporal relationship between the development of endophthalmitis, endocarditis, and the risk factors under interrogation. Additionally, the NIS does not contain detailed information about the patients with endophthalmitis including laterality of ocular involvement or presence of bilateral disease, visual acuity, duration of illness, and treatments provided. The use of ICD-9 codes does not allow our analysis to expand beyond those risk factors and diagnoses that have codes. As such, the codes used in this analysis may not be all encompassing. Methodology to identify cases used here has been described in the literature [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Finally, physicians may report codes inconsistently for patients or report data inaccurately, which may introduce error, as the quality of the provided data is dependent on the discharges from hospitals participating in the HCUP. Despite these limitations, we believe that this analysis using a nationally representative database represents an important contribution to the extant literature.</p><p id="Par24">This study identified risk factors for the development of EE in a cohort of inpatients with IE. Age &gt;20 years was associated with increased odds of developing concurrent EE. Hispanic and Asian or Pacific Islander patients had higher odds of developing EE as compared to Whites. There was no increased risk of EE with respect to the gender. The presence of diabetes with or without chronic complications, cardiac valvular disease, liver cirrhosis, and alcohol use disorder were each significantly associated with the presence of EE. The presence of congestive heart failure, arrhythmia, or a cardiac device significantly decreased the odds of developing EE. Patients with endophthalmitis had significantly greater inpatient lengths of stay, greater average cost of the hospitalization, and greater mortality. Being aware of the characteristics of these high-risk patient groups can increase physician awareness of infectious seeding in the eye and can raise the index of suspicion of EE when managing patients with IE. This heightened awareness can aide in early diagnosis, screening, and treatment of EE, which can have devastating visual complications if not treated promptly.</p></sec></sec><sec id="Sec6"><title>Summary</title><sec id="FPar1"><title>What was known before</title><p id="Par25">
<list list-type="bullet"><list-item><p id="Par26">Infectious endocarditis (IE) is a risk factor for endogenous endophthalmitis (EE), but the risk factors for EE in IE patients were not well understood.</p></list-item><list-item><p id="Par27">Previous studies have shown that certain demographic variables and comorbidities may influence the risk of EE in other infections.</p></list-item></list>
</p></sec><sec id="FPar2"><title>What this study adds</title><p id="Par28">
<list list-type="bullet"><list-item><p id="Par29">This study identified several risk factors for EE in IE patients, including age, ethnicity, and specific comorbidities.</p></list-item><list-item><p id="Par30">Older IE patients (21&#8211;64 years and 65+ years) and those of Hispanic or Asian/Pacific Islander ethnicity had a higher risk of developing EE.</p></list-item><list-item><p id="Par31">Comorbidities such as diabetes, alcohol use disorder, and cirrhosis increased risk of EE, while congestive heart failure, arrhythmia, and having a cardiac device decreased risk.</p></list-item></list>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Megh K. Shah, Aretha Zhu.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>All authors made significant contributions to the study. MKS was involved in study design, data collection, data analysis, data interpretation, literature search, writing, and critical revision. AZ was involved in study design, data collection, data interpretation, literature search, writing, and critical revision. AU was involved in study design, data collection, data analysis, data interpretation, and critical revision. RKH was involved in study design, data collection, and critical revision. MAZ was involved in writing and critical revision. NB was involved in study design, data interpretation, writing and critical revision.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated during and/or analysed during the current study are available in the 2002&#8211;2014 HCUP National Inpatient Sample (NIS) Database, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hcup-us.ahrq.gov/databases.jsp">www.hcup-us.ahrq.gov/databases.jsp</ext-link>.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par32">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okada</surname><given-names>AA</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>RP</given-names></name><name name-style="western"><surname>Liles</surname><given-names>WC</given-names></name><name name-style="western"><surname>D&#8217;Amico</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Baker</surname><given-names>AS</given-names></name></person-group><article-title>Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study</article-title><source>Ophthalmology</source><year>1994</year><volume>101</volume><fpage>832</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(13)31255-X</pub-id><pub-id pub-id-type="pmid">8190467</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Okada AA, Johnson RP, Liles WC, D&#8217;Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994;101:832&#8211;8.<pub-id pub-id-type="pmid">8190467</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiedler</surname><given-names>V</given-names></name><name name-style="western"><surname>Scott</surname><given-names>IU</given-names></name><name name-style="western"><surname>Flynn</surname><given-names>HW</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Davis</surname><given-names>JL</given-names></name><name name-style="western"><surname>Benz</surname><given-names>MS</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D</given-names></name></person-group><article-title>Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>137</volume><fpage>725</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2003.11.013</pub-id><pub-id pub-id-type="pmid">15059712</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Schiedler V, Scott IU, Flynn HW Jr., Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725&#8211;31. 10.1016/j.ajo.2003.11.013.<pub-id pub-id-type="pmid">15059712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajo.2003.11.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Sun</surname><given-names>MH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>NK</given-names></name><name name-style="western"><surname>Wu</surname><given-names>WC</given-names></name><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name></person-group><article-title>Endogenous Endophthalmitis Caused by Infective Endocarditis in East Asia</article-title><source>Ophthalmol Retin</source><year>2019</year><volume>3</volume><fpage>382</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.oret.2019.01.007</pub-id><pub-id pub-id-type="pmid">31014693</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Chen KJ, Sun MH, Chen YP, Wang NK, Wu WC, Lai CC. Endogenous Endophthalmitis Caused by Infective Endocarditis in East Asia. Ophthalmol Retin. 2019;3:382&#8211;4. 10.1016/j.oret.2019.01.007.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.oret.2019.01.007</pub-id><pub-id pub-id-type="pmid">31014693</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dugdale</surname><given-names>C</given-names></name><name name-style="western"><surname>Brown</surname><given-names>S</given-names></name><name name-style="western"><surname>Davila</surname><given-names>C</given-names></name><name name-style="western"><surname>Wolkow</surname><given-names>N</given-names></name><name name-style="western"><surname>Fishbein</surname><given-names>G</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><etal/></person-group><article-title>Out of Sight: Culture-Negative Endocarditis and Endophthalmitis</article-title><source>Am J Med</source><year>2017</year><volume>130</volume><fpage>e51</fpage><lpage>e53</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2016.08.029</pub-id><pub-id pub-id-type="pmid">27637598</pub-id><pub-id pub-id-type="pmcid">PMC5263175</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Dugdale C, Brown S, Davila C, Wolkow N, Fishbein G, Sun J, et al. Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. Am J Med. 2017;130:e51&#8211;e53. 10.1016/j.amjmed.2016.08.029.<pub-id pub-id-type="pmid">27637598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjmed.2016.08.029</pub-id><pub-id pub-id-type="pmcid">PMC5263175</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pras</surname><given-names>E</given-names></name><name name-style="western"><surname>Rubowitz</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferencz</surname><given-names>JR</given-names></name><name name-style="western"><surname>Raz</surname><given-names>J</given-names></name><name name-style="western"><surname>Rotenstreich</surname><given-names>Y</given-names></name><name name-style="western"><surname>Assia</surname><given-names>EI</given-names></name></person-group><article-title>Endogenous endophthalmitis as the leading sign of endocarditis</article-title><source>Ann Ophthalmol</source><year>2001</year><volume>33</volume><fpage>148</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s12009-001-0013-1</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Pras E, Rubowitz A, Ferencz JR, Raz J, Rotenstreich Y, Assia EI. Endogenous endophthalmitis as the leading sign of endocarditis. Ann Ophthalmol. 2001;33:148&#8211;50. 10.1007/s12009-001-0013-1.</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Yokokura</surname><given-names>S</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>T</given-names></name><name name-style="western"><surname>Mochizuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Maruyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases</article-title><source>BMC Ophthalmol</source><year>2020</year><volume>20</volume><fpage>126</fpage><pub-id pub-id-type="doi">10.1186/s12886-020-01378-0</pub-id><pub-id pub-id-type="pmid">32234022</pub-id><pub-id pub-id-type="pmcid">PMC7110777</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Yoshida M, Yokokura S, Nishida T, Mochizuki K, Suzuki T, Maruyama K, et al. Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases. BMC Ophthalmol. 2020;20:126. 10.1186/s12886-020-01378-0.<pub-id pub-id-type="pmid">32234022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12886-020-01378-0</pub-id><pub-id pub-id-type="pmcid">PMC7110777</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moradi</surname><given-names>P</given-names></name><name name-style="western"><surname>Roberton</surname><given-names>B</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>R</given-names></name><name name-style="western"><surname>Muhtaseb</surname><given-names>M</given-names></name><name name-style="western"><surname>Graham</surname><given-names>EM</given-names></name><name name-style="western"><surname>Klein</surname><given-names>J</given-names></name><etal/></person-group><article-title>HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess</article-title><source>Eye</source><year>2006</year><volume>20</volume><fpage>254</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/sj.eye.6701832</pub-id><pub-id pub-id-type="pmid">15688044</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Moradi P, Roberton B, Osborne R, Muhtaseb M, Graham EM, Klein J, et al. HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess. Eye. 2006;20:254&#8211;5. 10.1038/sj.eye.6701832.<pub-id pub-id-type="pmid">15688044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.eye.6701832</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shmuely</surname><given-names>H</given-names></name><name name-style="western"><surname>Kremer</surname><given-names>I</given-names></name><name name-style="western"><surname>Sagie</surname><given-names>A</given-names></name><name name-style="western"><surname>Pitlik</surname><given-names>S</given-names></name></person-group><article-title>Candida tropicalis multifocal endophthalmitis as the only initial manifestation of pacemaker endocarditis</article-title><source>Am J Ophthalmol</source><year>1997</year><volume>123</volume><fpage>559</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/s0002-9394(14)70189-8</pub-id><pub-id pub-id-type="pmid">9124260</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Shmuely H, Kremer I, Sagie A, Pitlik S. Candida tropicalis multifocal endophthalmitis as the only initial manifestation of pacemaker endocarditis. Am J Ophthalmol. 1997;123:559&#8211;60. 10.1016/s0002-9394(14)70189-8.<pub-id pub-id-type="pmid">9124260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9394(14)70189-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villasmil</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Lattanzio</surname><given-names>N</given-names></name><name name-style="western"><surname>Burns</surname><given-names>K</given-names></name><name name-style="western"><surname>Alkayali</surname><given-names>T</given-names></name></person-group><article-title>More Than Meets the Eye: Infective Endocarditis Presenting as Endogenous Endophthalmitis</article-title><source>Cureus</source><year>2021</year><volume>13</volume><fpage>e14745</fpage><pub-id pub-id-type="doi">10.7759/cureus.14745</pub-id><pub-id pub-id-type="pmid">34084673</pub-id><pub-id pub-id-type="pmcid">PMC8163352</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Villasmil RJ, Lattanzio N, Burns K, Alkayali T. More Than Meets the Eye: Infective Endocarditis Presenting as Endogenous Endophthalmitis. Cureus. 2021;13:e14745. 10.7759/cureus.14745.<pub-id pub-id-type="pmid">34084673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.14745</pub-id><pub-id pub-id-type="pmcid">PMC8163352</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barge</surname><given-names>S</given-names></name><name name-style="western"><surname>Rothwell</surname><given-names>R</given-names></name><name name-style="western"><surname>Varandas</surname><given-names>R</given-names></name><name name-style="western"><surname>Agrelos</surname><given-names>L</given-names></name></person-group><article-title>Enterococcus faecalis Endogenous Endophthalmitis from Valvular Endocarditis</article-title><source>Case Rep Ophthalmol Med</source><year>2013</year><volume>2013</volume><fpage>174869</fpage><pub-id pub-id-type="doi">10.1155/2013/174869</pub-id><pub-id pub-id-type="pmid">23936701</pub-id><pub-id pub-id-type="pmcid">PMC3713356</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Barge S, Rothwell R, Varandas R, Agrelos L. Enterococcus faecalis Endogenous Endophthalmitis from Valvular Endocarditis. Case Rep Ophthalmol Med. 2013;2013:174869 10.1155/2013/174869.<pub-id pub-id-type="pmid">23936701</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/174869</pub-id><pub-id pub-id-type="pmcid">PMC3713356</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>WT</given-names></name><name name-style="western"><surname>Grant</surname><given-names>M</given-names></name></person-group><article-title>Actinomyces neuii: a case report of a rare cause of acute infective endocarditis and literature review</article-title><source>BMC Infect Dis</source><year>2019</year><volume>19</volume><fpage>511</fpage><pub-id pub-id-type="doi">10.1186/s12879-019-4149-2</pub-id><pub-id pub-id-type="pmid">31182045</pub-id><pub-id pub-id-type="pmcid">PMC6558687</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Yang WT, Grant M. Actinomyces neuii: a case report of a rare cause of acute infective endocarditis and literature review. BMC Infect Dis. 2019;19:511 10.1186/s12879-019-4149-2.<pub-id pub-id-type="pmid">31182045</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-019-4149-2</pub-id><pub-id pub-id-type="pmcid">PMC6558687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. 2002-2014. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hcup-us.ahrq.gov/databases.jsp">www.hcup-us.ahrq.gov/databases.jsp</ext-link>.</mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mettler</surname><given-names>SK</given-names></name><name name-style="western"><surname>Alhariri</surname><given-names>H</given-names></name><name name-style="western"><surname>Okoli</surname><given-names>U</given-names></name><name name-style="western"><surname>Charoenngam</surname><given-names>N</given-names></name><name name-style="western"><surname>Guillen</surname><given-names>R</given-names></name><name name-style="western"><surname>Jaroenlapnopparat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Gender, Age, and Regional Disparities in the Incidence and Mortality Trends of Infective Endocarditis in the United States Between 1990 and 2019</article-title><source>Am J Cardiol</source><year>2023</year><volume>203</volume><fpage>128</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2023.07.018</pub-id><pub-id pub-id-type="pmid">37494864</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Mettler SK, Alhariri H, Okoli U, Charoenngam N, Guillen R, Jaroenlapnopparat A, et al. Gender, Age, and Regional Disparities in the Incidence and Mortality Trends of Infective Endocarditis in the United States Between 1990 and 2019. Am J Cardiol. 2023;203:128&#8211;35. 10.1016/j.amjcard.2023.07.018.<pub-id pub-id-type="pmid">37494864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjcard.2023.07.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budea</surname><given-names>CM</given-names></name><name name-style="western"><surname>Bratosin</surname><given-names>F</given-names></name><name name-style="western"><surname>Bogdan</surname><given-names>I</given-names></name><name name-style="western"><surname>Bota</surname><given-names>AV</given-names></name><name name-style="western"><surname>Turaiche</surname><given-names>M</given-names></name><name name-style="western"><surname>Tirnea</surname><given-names>L</given-names></name><etal/></person-group><article-title>Clinical Presentation and Risk Factors of Infective Endocarditis in the Elderly: A Systematic Review</article-title><source>J Pers Med</source><year>2023</year><volume>13</volume><fpage>296</fpage><pub-id pub-id-type="doi">10.3390/jpm13020296</pub-id><pub-id pub-id-type="pmid">36836530</pub-id><pub-id pub-id-type="pmcid">PMC9966560</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Budea CM, Bratosin F, Bogdan I, Bota AV, Turaiche M, Tirnea L, et al. Clinical Presentation and Risk Factors of Infective Endocarditis in the Elderly: A Systematic Review. J Pers Med. 2023;13:296 10.3390/jpm13020296.<pub-id pub-id-type="pmid">36836530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jpm13020296</pub-id><pub-id pub-id-type="pmcid">PMC9966560</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="book"><person-group person-group-type="author"><collab>Producing National HCUP Estimates - Accessible Version.</collab></person-group><source>Healthcare Cost and Utilization Project (HCUP)</source><year>2018</year><publisher-loc>Rockville, MD</publisher-loc><publisher-name>Agency for Healthcare Research and Quality</publisher-name></element-citation><mixed-citation id="mc-CR15" publication-type="book">Producing National HCUP Estimates - Accessible Version. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hcup-us.ahrq.gov/tech_assist/nationalestimates/508_course/508course_2018.jsp">www.hcup-us.ahrq.gov/tech_assist/nationalestimates/508_course/508course_2018.jsp</ext-link> Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2018.</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowak</surname><given-names>MS</given-names></name><name name-style="western"><surname>Grzybowski</surname><given-names>A</given-names></name><name name-style="western"><surname>Michalska-Ma&#322;ecka</surname><given-names>K</given-names></name><name name-style="western"><surname>Szaflik</surname><given-names>JP</given-names></name><name name-style="western"><surname>Kozio&#322;</surname><given-names>M</given-names></name><name name-style="western"><surname>Niemczyk</surname><given-names>W</given-names></name><etal/></person-group><article-title>Incidence and Characteristics of Endophthalmitis after Cataract Surgery in Poland, during 2010-2015</article-title><source>Int J Environ Res Public Health</source><year>2019</year><volume>16</volume><fpage>2188</fpage><pub-id pub-id-type="doi">10.3390/ijerph16122188</pub-id><pub-id pub-id-type="pmid">31226859</pub-id><pub-id pub-id-type="pmcid">PMC6617312</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Nowak MS, Grzybowski A, Michalska-Ma&#322;ecka K, Szaflik JP, Kozio&#322; M, Niemczyk W, et al. Incidence and Characteristics of Endophthalmitis after Cataract Surgery in Poland, during 2010-2015. Int J Environ Res Public Health. 2019;16:2188 10.3390/ijerph16122188.<pub-id pub-id-type="pmid">31226859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph16122188</pub-id><pub-id pub-id-type="pmcid">PMC6617312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uppuluri</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>Trends in Endogenous Endophthalmitis in Rural and Urban Settings in the United States</article-title><source>Ophthalmic Epidemiol</source><year>2023</year><volume>30</volume><fpage>300</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1080/09286586.2022.2094965</pub-id><pub-id pub-id-type="pmid">35848205</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Uppuluri A, Zarbin MA, Bhagat N. Trends in Endogenous Endophthalmitis in Rural and Urban Settings in the United States. Ophthalmic Epidemiol. 2023;30:300&#8211;6. 10.1080/09286586.2022.2094965.<pub-id pub-id-type="pmid">35848205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09286586.2022.2094965</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uppuluri</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Budoff</surname><given-names>G</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>Risk Factors for Endogenous Endophthalmitis in Hospitalized Patients with Candida Fungemia</article-title><source>Ophthalmol Retin</source><year>2021</year><volume>5</volume><fpage>687</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.oret.2020.10.007</pub-id><pub-id pub-id-type="pmid">33075547</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Uppuluri A, Zarbin MA, Budoff G, Bhagat N. Risk Factors for Endogenous Endophthalmitis in Hospitalized Patients with Candida Fungemia. Ophthalmol Retin. 2021;5:687&#8211;95. 10.1016/j.oret.2020.10.007.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.oret.2020.10.007</pub-id><pub-id pub-id-type="pmid">33075547</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uppuluri</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>Endogenous endophthalmitis in patients with intravenous opioid use: demographics and associated comorbidities</article-title><source>Int Ophthalmol</source><year>2021</year><volume>41</volume><fpage>1513</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s10792-021-01709-0</pub-id><pub-id pub-id-type="pmid">33506370</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Uppuluri A, Zarbin MA, Bhagat N. Endogenous endophthalmitis in patients with intravenous opioid use: demographics and associated comorbidities. Int Ophthalmol. 2021;41:1513&#8211;20. 10.1007/s10792-021-01709-0.<pub-id pub-id-type="pmid">33506370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10792-021-01709-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>RK</given-names></name><name name-style="western"><surname>Uppuluri</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>The Impact of Frailty Syndrome on Endogenous Endophthalmitis Development and Outcomes: A Population-Level Analysis</article-title><source>Ophthalmology</source><year>2022</year><volume>129</volume><fpage>1440</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2022.07.006</pub-id><pub-id pub-id-type="pmid">35843372</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Henry RK, Uppuluri A, Zarbin MA, Bhagat N. The Impact of Frailty Syndrome on Endogenous Endophthalmitis Development and Outcomes: A Population-Level Analysis. Ophthalmology. 2022;129:1440&#8211;7. 10.1016/j.ophtha.2022.07.006.<pub-id pub-id-type="pmid">35843372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ophtha.2022.07.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tookes</surname><given-names>H</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Khalid</surname><given-names>R</given-names></name><name name-style="western"><surname>Doblecki-Lewis</surname><given-names>S</given-names></name></person-group><article-title>A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0129360</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0129360</pub-id><pub-id pub-id-type="pmid">26075888</pub-id><pub-id pub-id-type="pmcid">PMC4468183</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S. A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida. PLoS One. 2015;10:e0129360 10.1371/journal.pone.0129360.<pub-id pub-id-type="pmid">26075888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0129360</pub-id><pub-id pub-id-type="pmcid">PMC4468183</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Guidance: Data sets not requiring IRB Review. National Bureau of Economic Research. 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nber.org/programs-projects/projects-and-centers/human-subjects-protection-and-institutional-review-board-irb/guidance-data-sets-not-requiring-irb-review">https://www.nber.org/programs-projects/projects-and-centers/human-subjects-protection-and-institutional-review-board-irb/guidance-data-sets-not-requiring-irb-review</ext-link>. Accessed March 8, 2023.</mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zibaeenezhad</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Moaref</surname><given-names>A</given-names></name><name name-style="western"><surname>Abtahi</surname><given-names>F</given-names></name><name name-style="western"><surname>Moghadami</surname><given-names>M</given-names></name><name name-style="western"><surname>Johari</surname><given-names>MK</given-names></name><name name-style="western"><surname>Ardekani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID-19: A case report</article-title><source>Clin Case Rep</source><year>2022</year><volume>10</volume><fpage>e05821</fpage><pub-id pub-id-type="doi">10.1002/ccr3.5821</pub-id><pub-id pub-id-type="pmid">35592043</pub-id><pub-id pub-id-type="pmcid">PMC9097135</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Zibaeenezhad MJ, Moaref A, Abtahi F, Moghadami M, Johari MK, Ardekani A, et al. Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID-19: A case report. Clin Case Rep. 2022;10:e05821 10.1002/ccr3.5821.<pub-id pub-id-type="pmid">35592043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ccr3.5821</pub-id><pub-id pub-id-type="pmcid">PMC9097135</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>M</given-names></name><name name-style="western"><surname>Sachdeva</surname><given-names>M</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S</given-names></name><name name-style="western"><surname>Shah</surname><given-names>H</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>RM</given-names></name><name name-style="western"><surname>Banker</surname><given-names>A</given-names></name></person-group><article-title>Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series</article-title><source>Ocul Immunol Inflamm</source><year>2021</year><volume>29</volume><fpage>726</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/09273948.2021.1945111</pub-id><pub-id pub-id-type="pmid">34255587</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Agarwal M, Sachdeva M, Pal S, Shah H, Kumar RM, Banker A. Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series. Ocul Immunol Inflamm. 2021;29:726&#8211;9. 10.1080/09273948.2021.1945111.<pub-id pub-id-type="pmid">34255587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09273948.2021.1945111</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>V</given-names></name><name name-style="western"><surname>Dogra</surname><given-names>MR</given-names></name><name name-style="western"><surname>Chakrabarti</surname><given-names>A</given-names></name><name name-style="western"><surname>Ray</surname><given-names>P</given-names></name><name name-style="western"><surname>Ram</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid</article-title><source>Retina</source><year>2000</year><volume>20</volume><fpage>262</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/00006982-200003000-00007</pub-id><pub-id pub-id-type="pmid">10872931</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Gupta A, Gupta V, Dogra MR, Chakrabarti A, Ray P, Ram J, et al. Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid. Retina. 2000;20:262&#8211;8.<pub-id pub-id-type="pmid">10872931</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mali</surname><given-names>JO</given-names></name><name name-style="western"><surname>Falk</surname><given-names>NS</given-names></name><name name-style="western"><surname>Mali</surname><given-names>YP</given-names></name><name name-style="western"><surname>Mencias</surname><given-names>L</given-names></name></person-group><article-title>Endogenous endophthalmitis with iris abscess after routine dental cleaning</article-title><source>JAMA Ophthalmol</source><year>2015</year><volume>133</volume><fpage>616</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2015.12</pub-id><pub-id pub-id-type="pmid">25719547</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Mali JO, Falk NS, Mali YP, Mencias L. Endogenous endophthalmitis with iris abscess after routine dental cleaning. JAMA Ophthalmol. 2015;133:616&#8211;7. 10.1001/jamaophthalmol.2015.12.<pub-id pub-id-type="pmid">25719547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaophthalmol.2015.12</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Oba</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hoshide</surname><given-names>S</given-names></name><name name-style="western"><surname>Arai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Komori</surname><given-names>T</given-names></name><name name-style="western"><surname>Kabutoya</surname><given-names>T</given-names></name><etal/></person-group><article-title>The Early Diagnosis of Endophthalmitis Due to Group B Streptococcus Infective Endocarditis and Its Clinical Course: A Case Report and Literature Review</article-title><source>Intern Med</source><year>2019</year><volume>58</volume><fpage>1295</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.2232-18</pub-id><pub-id pub-id-type="pmid">30626848</pub-id><pub-id pub-id-type="pmcid">PMC6543214</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Aoyama Y, Oba Y, Hoshide S, Arai Y, Komori T, Kabutoya T, et al. The Early Diagnosis of Endophthalmitis Due to Group B Streptococcus Infective Endocarditis and Its Clinical Course: A Case Report and Literature Review. Intern Med. 2019;58:1295&#8211;9. 10.2169/internalmedicine.2232-18.<pub-id pub-id-type="pmid">30626848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2169/internalmedicine.2232-18</pub-id><pub-id pub-id-type="pmcid">PMC6543214</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budoff</surname><given-names>G</given-names></name><name name-style="western"><surname>Thangamathesvaran</surname><given-names>L</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>Bacterial Endogenous Endophthalmitis in Bacteremic Inpatients</article-title><source>Ophthalmol Retin</source><year>2019</year><volume>3</volume><fpage>971</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.oret.2019.06.004</pub-id><pub-id pub-id-type="pmid">31446028</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Budoff G, Thangamathesvaran L, Zarbin MA, Bhagat N. Bacterial Endogenous Endophthalmitis in Bacteremic Inpatients. Ophthalmol Retin. 2019;3:971&#8211;8. 10.1016/j.oret.2019.06.004.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.oret.2019.06.004</pub-id><pub-id pub-id-type="pmid">31446028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Surles</surname><given-names>T</given-names></name><name name-style="western"><surname>Brown</surname><given-names>A</given-names></name></person-group><article-title>Endophthalmitis and Mycotic Aneurysm: The Only Clues to Underlying Endocarditis</article-title><source>Clin Pr Cases Emerg Med</source><year>2018</year><volume>2</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.5811/cpcem.2017.8.34723</pub-id><pub-id pub-id-type="pmcid">PMC5965132</pub-id><pub-id pub-id-type="pmid">29849250</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Carmelli G, Surles T, Brown A. Endophthalmitis and Mycotic Aneurysm: The Only Clues to Underlying Endocarditis. Clin Pr Cases Emerg Med. 2018;2:16&#8211;20. 10.5811/cpcem.2017.8.34723.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5811/cpcem.2017.8.34723</pub-id><pub-id pub-id-type="pmcid">PMC5965132</pub-id><pub-id pub-id-type="pmid">29849250</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Morillas</surname><given-names>JA</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Taege</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C</given-names></name><name name-style="western"><surname>Popovic</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Histoplasma capsulatum Pacemaker-related Endocarditis Presenting as Endogenous Endophthalmitis</article-title><source>Retin Cases Brief Rep</source><year>2024</year><volume>18</volume><fpage>145</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/ICB.0000000000001326</pub-id><pub-id pub-id-type="pmid">36731111</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Chen C, Morillas JA, Rehm SJ, Taege AJ, Tan C, Popovic Z, et al. Histoplasma capsulatum Pacemaker-related Endocarditis Presenting as Endogenous Endophthalmitis. Retin Cases Brief Rep. 2024;18:145&#8211;8. 10.1097/ICB.0000000000001326.<pub-id pub-id-type="pmid">36731111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ICB.0000000000001326</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durand</surname><given-names>ML</given-names></name></person-group><article-title>Endophthalmitis</article-title><source>Clin Microbiol Infect</source><year>2013</year><volume>19</volume><fpage>227</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12118</pub-id><pub-id pub-id-type="pmid">23438028</pub-id><pub-id pub-id-type="pmcid">PMC3638360</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19:227&#8211;34. 10.1111/1469-0691.12118.<pub-id pub-id-type="pmid">23438028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1469-0691.12118</pub-id><pub-id pub-id-type="pmcid">PMC3638360</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luong</surname><given-names>PM</given-names></name><name name-style="western"><surname>Tsui</surname><given-names>E</given-names></name><name name-style="western"><surname>Batra</surname><given-names>NN</given-names></name><name name-style="western"><surname>Zegans</surname><given-names>ME</given-names></name></person-group><article-title>Endogenous endophthalmitis and other ocular manifestations of injection drug use</article-title><source>Curr Opin Ophthalmol</source><year>2019</year><volume>30</volume><fpage>506</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/icu.0000000000000606</pub-id><pub-id pub-id-type="pmid">31589187</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Luong PM, Tsui E, Batra NN, Zegans ME. Endogenous endophthalmitis and other ocular manifestations of injection drug use. Curr Opin Ophthalmol. 2019;30:506&#8211;12. 10.1097/icu.0000000000000606.<pub-id pub-id-type="pmid">31589187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ICU.0000000000000606</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durand</surname><given-names>ML</given-names></name></person-group><article-title>Bacterial and Fungal Endophthalmitis</article-title><source>Clin Microbiol Rev</source><year>2017</year><volume>30</volume><fpage>597</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1128/cmr.00113-16</pub-id><pub-id pub-id-type="pmid">28356323</pub-id><pub-id pub-id-type="pmcid">PMC5475221</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev. 2017;30:597&#8211;613. 10.1128/cmr.00113-16.<pub-id pub-id-type="pmid">28356323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.00113-16</pub-id><pub-id pub-id-type="pmcid">PMC5475221</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>YR</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>SW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Infective Endocarditis Presenting as Endogenous Endophthalmitis Secondary to Streptococcus agalactiae in a Healthy Adult: Case Reports and Literature Review</article-title><source>Infect Chemother</source><year>2017</year><volume>49</volume><fpage>286</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.3947/ic.2017.49.4.286</pub-id><pub-id pub-id-type="pmid">29299896</pub-id><pub-id pub-id-type="pmcid">PMC5754340</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sim YR, Lee YJ, Park SW, Kim SH, Choi JH, Choi JY, et al. Infective Endocarditis Presenting as Endogenous Endophthalmitis Secondary to Streptococcus agalactiae in a Healthy Adult: Case Reports and Literature Review. Infect Chemother. 2017;49:286&#8211;92. 10.3947/ic.2017.49.4.286.<pub-id pub-id-type="pmid">29299896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3947/ic.2017.49.4.286</pub-id><pub-id pub-id-type="pmcid">PMC5754340</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danielescu</surname><given-names>C</given-names></name><name name-style="western"><surname>Anton</surname><given-names>N</given-names></name><name name-style="western"><surname>Stanca</surname><given-names>HT</given-names></name><name name-style="western"><surname>Munteanu</surname><given-names>M</given-names></name></person-group><article-title>Endogenous Endophthalmitis: A Review of Case Series Published between 2011 and 2020</article-title><source>J Ophthalmol</source><year>2020</year><volume>2020</volume><fpage>8869590</fpage><pub-id pub-id-type="doi">10.1155/2020/8869590</pub-id><pub-id pub-id-type="pmid">33149945</pub-id><pub-id pub-id-type="pmcid">PMC7603614</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous Endophthalmitis: A Review of Case Series Published between 2011 and 2020. J Ophthalmol. 2020;2020:8869590 10.1155/2020/8869590.<pub-id pub-id-type="pmid">33149945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/8869590</pub-id><pub-id pub-id-type="pmcid">PMC7603614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#216;stergaard</surname><given-names>L</given-names></name><name name-style="western"><surname>Mogensen</surname><given-names>UM</given-names></name><name name-style="western"><surname>Bundgaard</surname><given-names>JS</given-names></name><name name-style="western"><surname>Dahl</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A</given-names></name><name name-style="western"><surname>Torp-Pedersen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Duration and complications of diabetes mellitus and the associated risk of infective endocarditis</article-title><source>Int J Cardiol</source><year>2019</year><volume>278</volume><fpage>280</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2018.09.106</pub-id><pub-id pub-id-type="pmid">30291010</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">&#216;stergaard L, Mogensen UM, Bundgaard JS, Dahl A, Wang A, Torp-Pedersen C, et al. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. Int J Cardiol. 2019;278:280&#8211;4. 10.1016/j.ijcard.2018.09.106.<pub-id pub-id-type="pmid">30291010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2018.09.106</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>XB</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>XL</given-names></name><name name-style="western"><surname>Yu</surname><given-names>DQ</given-names></name><name name-style="western"><surname>Tan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prediabetes and diabetes are both risk factors for adverse outcomes in infective endocarditis</article-title><source>Diabet Med</source><year>2018</year><volume>35</volume><fpage>1499</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1111/dme.13761</pub-id><pub-id pub-id-type="pmid">29908070</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wei XB, Liu YH, Huang JL, Chen XL, Yu DQ, Tan N, et al. Prediabetes and diabetes are both risk factors for adverse outcomes in infective endocarditis. Diabet Med. 2018;35:1499&#8211;507. 10.1111/dme.13761.<pub-id pub-id-type="pmid">29908070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dme.13761</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Mahaling B, Low SWY, Beck M, Kumar D, Ahmed S, Connor TB, et al. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders. Int J Mol Sci. 2022;23. 10.3390/ijms23052591.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms23052591</pub-id><pub-id pub-id-type="pmcid">PMC8910759</pub-id><pub-id pub-id-type="pmid">35269741</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>HF</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>AS</given-names></name></person-group><article-title>Native-Valve Infective Endocarditis</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>567</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1056/NEJMcp2000400</pub-id><pub-id pub-id-type="pmid">32757525</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Chambers HF, Bayer AS. Native-Valve Infective Endocarditis. N Engl J Med. 2020;383:567&#8211;76. 10.1056/NEJMcp2000400.<pub-id pub-id-type="pmid">32757525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMcp2000400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexis</surname><given-names>SL</given-names></name><name name-style="western"><surname>Malik</surname><given-names>AH</given-names></name><name name-style="western"><surname>George</surname><given-names>I</given-names></name><name name-style="western"><surname>Hahn</surname><given-names>RT</given-names></name><name name-style="western"><surname>Khalique</surname><given-names>OK</given-names></name><name name-style="western"><surname>Seetharam</surname><given-names>K</given-names></name><etal/></person-group><article-title>Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review</article-title><source>J Am Heart Assoc</source><year>2020</year><volume>9</volume><fpage>e017347</fpage><pub-id pub-id-type="doi">10.1161/jaha.120.017347</pub-id><pub-id pub-id-type="pmid">32772772</pub-id><pub-id pub-id-type="pmcid">PMC7660802</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Alexis SL, Malik AH, George I, Hahn RT, Khalique OK, Seetharam K, et al. Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review. J Am Heart Assoc. 2020;9:e017347 10.1161/jaha.120.017347.<pub-id pub-id-type="pmid">32772772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.120.017347</pub-id><pub-id pub-id-type="pmcid">PMC7660802</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyall</surname><given-names>DA</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>ME</given-names></name><name name-style="western"><surname>McDonnell</surname><given-names>J</given-names></name><name name-style="western"><surname>De Villiers</surname><given-names>F</given-names></name><name name-style="western"><surname>Tejwani</surname><given-names>D</given-names></name></person-group><article-title>Bilateral endogenous Serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery</article-title><source>Scott Med J</source><year>2013</year><volume>58</volume><fpage>e1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1177/0036933013482647</pub-id><pub-id pub-id-type="pmid">23728762</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Lyall DA, Gregory ME, McDonnell J, De Villiers F, Tejwani D. Bilateral endogenous Serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery. Scott Med J. 2013;58:e1&#8211;6. 10.1177/0036933013482647.<pub-id pub-id-type="pmid">23728762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0036933013482647</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saffra</surname><given-names>NA</given-names></name><name name-style="western"><surname>Desai</surname><given-names>RU</given-names></name><name name-style="western"><surname>Seidman</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Chapnick</surname><given-names>EK</given-names></name></person-group><article-title>Endogenous fungal endophthalmitis after cardiac surgery</article-title><source>Ophthalmic Surg Lasers Imaging</source><year>2010</year><volume>41</volume><fpage>e1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.3928/15428877-20101025-08</pub-id><pub-id pub-id-type="pmid">21053864</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Saffra NA, Desai RU, Seidman CJ, Chapnick EK. Endogenous fungal endophthalmitis after cardiac surgery. Ophthalmic Surg Lasers Imaging. 2010;41:e1&#8211;3. 10.3928/15428877-20101025-08.<pub-id pub-id-type="pmid">21053864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3928/15428877-20101025-08</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>C</given-names></name><name name-style="western"><surname>Conigrave</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lewohl</surname><given-names>J</given-names></name><name name-style="western"><surname>Haber</surname><given-names>P</given-names></name><name name-style="western"><surname>Morley</surname><given-names>KC</given-names></name></person-group><article-title>Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis</article-title><source>Brain Behav Immun</source><year>2020</year><volume>89</volume><fpage>501</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2020.08.002</pub-id><pub-id pub-id-type="pmid">32805393</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Adams C, Conigrave JH, Lewohl J, Haber P, Morley KC. Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain Behav Immun. 2020;89:501&#8211;12. 10.1016/j.bbi.2020.08.002.<pub-id pub-id-type="pmid">32805393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbi.2020.08.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rachdaoui</surname><given-names>N</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>DK</given-names></name></person-group><article-title>Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System</article-title><source>Alcohol Res</source><year>2017</year><volume>38</volume><fpage>255</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">28988577</pub-id><pub-id pub-id-type="pmcid">PMC5513689</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Rachdaoui N, Sarkar DK. Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System. Alcohol Res. 2017;38:255&#8211;76.<pub-id pub-id-type="pmid">28988577</pub-id><pub-id pub-id-type="pmcid">PMC5513689</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spies</surname><given-names>CD</given-names></name><name name-style="western"><surname>von Dossow</surname><given-names>V</given-names></name><name name-style="western"><surname>Eggers</surname><given-names>V</given-names></name><name name-style="western"><surname>Jetschmann</surname><given-names>G</given-names></name><name name-style="western"><surname>El-Hilali</surname><given-names>R</given-names></name><name name-style="western"><surname>Egert</surname><given-names>J</given-names></name><etal/></person-group><article-title>Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><fpage>1088</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1097/00000542-200405000-00010</pub-id><pub-id pub-id-type="pmid">15114205</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Spies CD, von Dossow V, Eggers V, Jetschmann G, El-Hilali R, Egert J, et al. Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology. 2004;100:1088&#8211;100. 10.1097/00000542-200405000-00010.<pub-id pub-id-type="pmid">15114205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-200405000-00010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>H</given-names></name><name name-style="western"><surname>Shin</surname><given-names>YU</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>NH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>HG</given-names></name><name name-style="western"><surname>Sobrin</surname><given-names>L</given-names></name><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study</article-title><source>Ocul Immunol Inflamm</source><year>2018</year><volume>26</volume><fpage>496</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1080/09273948.2016.1195000</pub-id><pub-id pub-id-type="pmid">27459423</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A, et al. Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study. Ocul Immunol Inflamm. 2018;26:496&#8211;503. 10.1080/09273948.2016.1195000.<pub-id pub-id-type="pmid">27459423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09273948.2016.1195000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corredores</surname><given-names>J</given-names></name><name name-style="western"><surname>Hemo</surname><given-names>I</given-names></name><name name-style="western"><surname>Jaouni</surname><given-names>T</given-names></name><name name-style="western"><surname>Habot-Wilner</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>M</given-names></name><name name-style="western"><surname>Shulman</surname><given-names>S</given-names></name><etal/></person-group><article-title>Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients</article-title><source>Int J Ophthalmol</source><year>2021</year><volume>14</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.18240/ijo.2021.01.14</pub-id><pub-id pub-id-type="pmid">33469490</pub-id><pub-id pub-id-type="pmcid">PMC7790672</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Corredores J, Hemo I, Jaouni T, Habot-Wilner Z, Kramer M, Shulman S, et al. Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients. Int J Ophthalmol. 2021;14:97&#8211;105. 10.18240/ijo.2021.01.14.<pub-id pub-id-type="pmid">33469490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18240/ijo.2021.01.14</pub-id><pub-id pub-id-type="pmcid">PMC7790672</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Um</surname><given-names>T</given-names></name><name name-style="western"><surname>Joe</surname><given-names>SG</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea</article-title><source>Retina</source><year>2012</year><volume>32</volume><fpage>977</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1097/IAE.0b013e318228e312</pub-id><pub-id pub-id-type="pmid">22105504</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Lee S, Um T, Joe SG, Hwang J, Kim J, Yoon YH, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012;32:977&#8211;84. 10.1097/IAE.0b013e318228e312.<pub-id pub-id-type="pmid">22105504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IAE.0b013e318228e312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albillos</surname><given-names>A</given-names></name><name name-style="western"><surname>Martin-Mateos</surname><given-names>R</given-names></name><name name-style="western"><surname>Van der Merwe</surname><given-names>S</given-names></name><name name-style="western"><surname>Wiest</surname><given-names>R</given-names></name><name name-style="western"><surname>Jalan</surname><given-names>R</given-names></name><name name-style="western"><surname>&#193;lvarez-Mon</surname><given-names>M</given-names></name></person-group><article-title>Cirrhosis-associated immune dysfunction</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2022</year><volume>19</volume><fpage>112</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1038/s41575-021-00520-7</pub-id><pub-id pub-id-type="pmid">34703031</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, &#193;lvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022;19:112&#8211;34. 10.1038/s41575-021-00520-7.<pub-id pub-id-type="pmid">34703031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41575-021-00520-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krenzien</surname><given-names>F</given-names></name><name name-style="western"><surname>ElKhal</surname><given-names>A</given-names></name><name name-style="western"><surname>Quante</surname><given-names>M</given-names></name><name name-style="western"><surname>Biefer</surname><given-names>HRC</given-names></name><name name-style="western"><surname>Hirofumi</surname><given-names>U</given-names></name><name name-style="western"><surname>Gabardi</surname><given-names>S</given-names></name><etal/></person-group><article-title>A Rationale for Age-Adapted Immunosuppression in Organ Transplantation</article-title><source>Transplantation</source><year>2015</year><volume>99</volume><fpage>2258</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1097/tp.0000000000000842</pub-id><pub-id pub-id-type="pmid">26244716</pub-id><pub-id pub-id-type="pmcid">PMC4618718</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Krenzien F, ElKhal A, Quante M, Biefer HRC, Hirofumi U, Gabardi S, et al. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation. Transplantation. 2015;99:2258&#8211;68. 10.1097/tp.0000000000000842.<pub-id pub-id-type="pmid">26244716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TP.0000000000000842</pub-id><pub-id pub-id-type="pmcid">PMC4618718</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heitmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Cometta</surname><given-names>A</given-names></name><name name-style="western"><surname>Hurni</surname><given-names>M</given-names></name><name name-style="western"><surname>Aebischer</surname><given-names>N</given-names></name><name name-style="western"><surname>Tschan-Schild</surname><given-names>I</given-names></name><name name-style="western"><surname>Bille</surname><given-names>J</given-names></name></person-group><article-title>Right-sided pacemaker-related endocarditis due to Acremonium species</article-title><source>Clin Infect Dis</source><year>1997</year><volume>25</volume><fpage>158</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1086/516892</pub-id><pub-id pub-id-type="pmid">9243056</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Heitmann L, Cometta A, Hurni M, Aebischer N, Tschan-Schild I, Bille J. Right-sided pacemaker-related endocarditis due to Acremonium species. Clin Infect Dis. 1997;25:158&#8211;60. 10.1086/516892.<pub-id pub-id-type="pmid">9243056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/516892</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mejaddam</surname><given-names>A</given-names></name><name name-style="western"><surname>Pircher</surname><given-names>A</given-names></name></person-group><article-title>Aggregatibacter Endophthalmitis in a patient with Dentophobia</article-title><source>Retin Cases Brief Rep</source><year>2024</year><volume>18</volume><fpage>135</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/ICB.0000000000001335</pub-id><pub-id pub-id-type="pmid">36007190</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Mejaddam A, Pircher A. Aggregatibacter Endophthalmitis in a patient with Dentophobia. Retin Cases Brief Rep. 2024;18:135&#8211;7. 10.1097/ICB.0000000000001335.<pub-id pub-id-type="pmid">36007190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ICB.0000000000001335</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pride</surname><given-names>P</given-names></name><name name-style="western"><surname>Nutaitis</surname><given-names>M</given-names></name><name name-style="western"><surname>Charity</surname><given-names>PL</given-names></name></person-group><article-title>Endophthalmitis: an unusual presentation of bacteremia</article-title><source>Am J Med Sci</source><year>2013</year><volume>345</volume><fpage>70</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1097/MAJ.0b013e31825fa570</pub-id><pub-id pub-id-type="pmid">23262812</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Pride P, Nutaitis M, Charity PL. Endophthalmitis: an unusual presentation of bacteremia. Am J Med Sci. 2013;345:70&#8211;1. 10.1097/MAJ.0b013e31825fa570.<pub-id pub-id-type="pmid">23262812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MAJ.0b013e31825fa570</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#268;elutkien&#279;</surname><given-names>J</given-names></name><name name-style="western"><surname>Spoletini</surname><given-names>I</given-names></name><name name-style="western"><surname>Coats</surname><given-names>AJS</given-names></name><name name-style="western"><surname>Chioncel</surname><given-names>O</given-names></name></person-group><article-title>Left ventricular function monitoring in heart failure</article-title><source>Eur Heart J Suppl</source><year>2019</year><volume>21</volume><fpage>M17</fpage><lpage>m19</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/suz218</pub-id><pub-id pub-id-type="pmid">31908610</pub-id><pub-id pub-id-type="pmcid">PMC6937514</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">&#268;elutkien&#279; J, Spoletini I, Coats AJS, Chioncel O. Left ventricular function monitoring in heart failure. Eur Heart J Suppl. 2019;21:M17&#8211;m19. 10.1093/eurheartj/suz218.<pub-id pub-id-type="pmid">31908610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/suz218</pub-id><pub-id pub-id-type="pmcid">PMC6937514</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uppuluri</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>S</given-names></name><name name-style="western"><surname>Zarbin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhagat</surname><given-names>N</given-names></name></person-group><article-title>Central retinal artery occlusion with atrial fibrillation or atrial flutter</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2021</year><volume>259</volume><fpage>1673</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s00417-020-05014-x</pub-id><pub-id pub-id-type="pmid">33191472</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Uppuluri A, Bhagat S, Zarbin MA, Bhagat N. Central retinal artery occlusion with atrial fibrillation or atrial flutter. Graefes Arch Clin Exp Ophthalmol. 2021;259:1673&#8211;6. 10.1007/s00417-020-05014-x.<pub-id pub-id-type="pmid">33191472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00417-020-05014-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavin</surname><given-names>P</given-names></name><name name-style="western"><surname>Patrylo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hollar</surname><given-names>M</given-names></name><name name-style="western"><surname>Espaillat</surname><given-names>KB</given-names></name><name name-style="western"><surname>Kirshner</surname><given-names>H</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>M</given-names></name></person-group><article-title>Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion</article-title><source>Am J Ophthalmol</source><year>2018</year><volume>196</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2018.08.027</pub-id><pub-id pub-id-type="pmid">30153430</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Lavin P, Patrylo M, Hollar M, Espaillat KB, Kirshner H, Schrag M. Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion. Am J Ophthalmol. 2018;196:96&#8211;100. 10.1016/j.ajo.2018.08.027.<pub-id pub-id-type="pmid">30153430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajo.2018.08.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varma</surname><given-names>DD</given-names></name><name name-style="western"><surname>Cugati</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>AW</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name></person-group><article-title>A review of central retinal artery occlusion: clinical presentation and management</article-title><source>Eye</source><year>2013</year><volume>27</volume><fpage>688</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1038/eye.2013.25</pub-id><pub-id pub-id-type="pmid">23470793</pub-id><pub-id pub-id-type="pmcid">PMC3682348</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye. 2013;27:688&#8211;97. 10.1038/eye.2013.25.<pub-id pub-id-type="pmid">23470793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/eye.2013.25</pub-id><pub-id pub-id-type="pmcid">PMC3682348</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirera</surname><given-names>I</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>TM</given-names></name><name name-style="western"><surname>Navasa</surname><given-names>M</given-names></name><name name-style="western"><surname>Vila</surname><given-names>J</given-names></name><name name-style="western"><surname>Grande</surname><given-names>L</given-names></name><name name-style="western"><surname>Taur&#225;</surname><given-names>P</given-names></name><etal/></person-group><article-title>Bacterial translocation of enteric organisms in patients with cirrhosis</article-title><source>J Hepatol</source><year>2001</year><volume>34</volume><fpage>32</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/s0168-8278(00)00013-1</pub-id><pub-id pub-id-type="pmid">11211904</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taur&#225; P, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34:32&#8211;7. 10.1016/s0168-8278(00)00013-1.<pub-id pub-id-type="pmid">11211904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0168-8278(00)00013-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stratton</surname><given-names>M</given-names></name><name name-style="western"><surname>Capitena</surname><given-names>C</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>L</given-names></name><name name-style="western"><surname>Paciuc-Beja</surname><given-names>M</given-names></name></person-group><article-title>Escherichia coli Eyelid Abscess in a Patient with Alcoholic Cirrhosis</article-title><source>Case Rep Ophthalmol Med</source><year>2015</year><volume>2015</volume><fpage>827609</fpage><pub-id pub-id-type="doi">10.1155/2015/827609</pub-id><pub-id pub-id-type="pmid">26451264</pub-id><pub-id pub-id-type="pmcid">PMC4587434</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Stratton M, Capitena C, Christensen L, Paciuc-Beja M. Escherichia coli Eyelid Abscess in a Patient with Alcoholic Cirrhosis. Case Rep Ophthalmol Med. 2015;2015:827609 10.1155/2015/827609.<pub-id pub-id-type="pmid">26451264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2015/827609</pub-id><pub-id pub-id-type="pmcid">PMC4587434</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seidelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Fleece</surname><given-names>M</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>A</given-names></name><name name-style="western"><surname>Lydon</surname><given-names>E</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>C</given-names></name><etal/></person-group><article-title>Endogenous Candida endophthalmitis: Who is really at risk?</article-title><source>J Infect</source><year>2021</year><volume>82</volume><fpage>276</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.12.032</pub-id><pub-id pub-id-type="pmid">33412206</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Seidelman J, Fleece M, Bloom A, Lydon E, Yang W, Arnold C, et al. Endogenous Candida endophthalmitis: Who is really at risk? J Infect. 2021;82:276&#8211;81. 10.1016/j.jinf.2020.12.032.<pub-id pub-id-type="pmid">33412206</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinf.2020.12.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ng</surname><given-names>DS</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>K</given-names></name><name name-style="western"><surname>Peng</surname><given-names>K</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H</given-names></name><etal/></person-group><article-title>Risk factors for endophthalmitis requiring evisceration or enucleation</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>28100</fpage><pub-id pub-id-type="doi">10.1038/srep28100</pub-id><pub-id pub-id-type="pmid">27302573</pub-id><pub-id pub-id-type="pmcid">PMC4908388</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Lu X, Ng DS, Zheng K, Peng K, Jin C, Xia H, et al. Risk factors for endophthalmitis requiring evisceration or enucleation. Sci Rep. 2016;6:28100 10.1038/srep28100.<pub-id pub-id-type="pmid">27302573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep28100</pub-id><pub-id pub-id-type="pmcid">PMC4908388</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abou-Jaoude</surname><given-names>M</given-names></name><name name-style="western"><surname>Oberst</surname><given-names>G</given-names></name><name name-style="western"><surname>Coyne</surname><given-names>L</given-names></name><name name-style="western"><surname>Cherry</surname><given-names>A</given-names></name><name name-style="western"><surname>Moore</surname><given-names>D</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name></person-group><article-title>Fundus Findings in Endocarditis: results of a new screening protocol for endogenous endophthalmitis</article-title><source>Investigative Ophthalmol Vis Sci</source><year>2019</year><volume>60</volume><fpage>2030</fpage><lpage>2030</lpage></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Abou-Jaoude M, Oberst G, Coyne L, Cherry A, Moore D, Fraser C. Fundus Findings in Endocarditis: results of a new screening protocol for endogenous endophthalmitis. Investigative Ophthalmol Vis Sci. 2019;60:2030&#8211;2030.</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breazzano</surname><given-names>MP</given-names></name><name name-style="western"><surname>Bond</surname><given-names>JB</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Bearelly</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Donahue</surname><given-names>SP</given-names></name><name name-style="western"><surname>Lum</surname><given-names>F</given-names></name><etal/></person-group><article-title>American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis</article-title><source>Ophthalmology</source><year>2022</year><volume>129</volume><fpage>73</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2021.07.015</pub-id><pub-id pub-id-type="pmid">34293405</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Breazzano MP, Bond JB 3rd, Bearelly S, Kim DH, Donahue SP, Lum F, et al. American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis. Ophthalmology. 2022;129:73&#8211;6. 10.1016/j.ophtha.2021.07.015.<pub-id pub-id-type="pmid">34293405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ophtha.2021.07.015</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>